207940 fundamentals
An in-depth look to SAMSUNG BIOLOGICS operating, investing, and financing activities
207940 free cash flow for Q1 24 is 211.4 B KRW. For 2023, 207940 free cash flow was 671.16 B KRW and operating cash flow was 1.67 T KRW.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM